• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Agile Therapeutics, Inc. - Common Stock (NQ:AGRX)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 0.2400 (9)
Ask (Size) 0.2407 (5)
Prev. Close 0.6022
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 6,904,498
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
AGRX Stock Earnings: Agile Therapeutics Misses EPS, Beats Revenue for Q1 2024 ↗
May 15, 2024
AGRX stock results show that Agile Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 15, 2024
From Agile Therapeutics, Inc.
Via GlobeNewswire

Performance

More News

Read More
News headline image
AGRX Stock Earnings: Agile Therapeutics Misses EPS, Misses Revenue for Q4 2023 ↗
March 29, 2024
Via InvestorPlace
News headline image
Agile Therapeutics: Q4 Earnings Insights ↗
March 28, 2024
Via Benzinga
News headline image
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
March 28, 2024
From Agile Therapeutics, Inc.
Via GlobeNewswire
News headline image
Agile Therapeutics's Earnings: A Preview ↗
March 27, 2024
Via Benzinga
News headline image
Agile Therapeutics's Earnings: A Preview ↗
March 21, 2024
Via Benzinga
News headline image
Why Agile Therapeutics (AGRX) Stock Is Down 60% ↗
March 26, 2024
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
March 25, 2024
Via Benzinga
News headline image
Agile Therapeutics Announces Delisting from Nasdaq
March 25, 2024
From Agile Therapeutics, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For March 22, 2024 ↗
March 22, 2024
Via Benzinga
News headline image
Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024
March 21, 2024
From Agile Therapeutics, Inc.
Via GlobeNewswire
News headline image
Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024
March 20, 2024
From Agile Therapeutics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
March 13, 2024
Via Benzinga
News headline image
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
March 13, 2024
From Agile Therapeutics, Inc.
Via GlobeNewswire
News headline image
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
February 22, 2024
Via Benzinga
News headline image
What's Going On With Women Health Focused Agile Therapeutics Stock Today? ↗
February 22, 2024
Via Benzinga
News headline image
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
February 22, 2024
From Agile Therapeutics, Inc.
Via GlobeNewswire
News headline image
Why Is Bel Fuse (BELFB) Stock Down 17% Today? ↗
February 22, 2024
Via InvestorPlace
News headline image
Why Is Draganfly (DPRO) Stock Down 48% Today? ↗
February 22, 2024
Via InvestorPlace
News headline image
Why Is BuzzFeed (BZFD) Stock Up 101% Today? ↗
February 22, 2024
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
February 22, 2024
Via Benzinga
News headline image
Why Is Agile Therapeutics (AGRX) Stock Up 87% Today? ↗
February 22, 2024
Via InvestorPlace
News headline image
Why NVIDIA Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket ↗
February 22, 2024
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
February 22, 2024
Via InvestorPlace

Frequently Asked Questions

Is Agile Therapeutics, Inc. - Common Stock publicly traded?
Yes, Agile Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Agile Therapeutics, Inc. - Common Stock trade on?
Agile Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Agile Therapeutics, Inc. - Common Stock?
The ticker symbol for Agile Therapeutics, Inc. - Common Stock is AGRX on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap